Reimbursement issues in healthcare: a guide to resolution

Reimbursement issues in the healthcare industry are complex, but reimbursement is essential for healthcare organizations. Proper reimbursement allows providers to run operations efficiently and deliver consistent, high-quality patient care. It also enables organizations to invest in technologies that advance their operations. Read on to learn more about the causes of reimbursement issues and discover the…

Read More

Beyond Generative AI

By BENJAMIN EASTON Healthcare’s administrative burden is not a documentation problem. It is a workflow problem. Healthcare’s next leap depends on agentic systems that can actually do the work Over the past year, healthcare organizations have widely adopted generative AI for an array of documentation-related activities such as drafting appeal letters, producing patient-friendly summaries, and…

Read More

Why Providence Wants to Sell Its Health Plan

Providence announced its intent to sell its health plan, exiting the “payvider” model as rising costs and operational complexity weigh on smaller regional insurers. The move reflects a broader trend of health systems refocusing on core care delivery and exploring partnerships instead of running insurance themselves. The post Why Providence Wants to Sell Its Health…

Read More

Insurance eligibility checks: how automation reduces denials and delays

Patients expect clear information about their insurance coverage when they visit their healthcare provider, but too many leave feeling confused and financially underprepared. Experian Health’s State of Patient Access 2024 survey reveals that 56% of patients struggle to make sense of their insurance coverage without provider assistance, while 61% say improving coverage explanations is the…

Read More

Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case

Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.

Read More